Mean thrombocyte volume (MPV) and platelet lymphocyte ratio (PLR) from platelet indices used to assess platelet activation and function have been associated with a number of diseases in recent years. Laboratory studies should be considered when evaluating MPV and PLR tests. More detailed studies on MPV and PLR is needed in Laryngeal Carcinoma. J Clin Exp Invest 2016; 7(4): 294-295 
I read Yilmaz et al. the interesting study 'Prognostic Value of Mean Platelet Volume and Platelet-Lymphocyte
Ratio in Laryngeal Carcinoma' published in the last issue of your journal. I congratulate the authors and friends for this study. In addition to studying, I have a few contributors to the parameters for readers and authors.
MPV and PLR tests studying were not informed to the patient and control group on the same day and on the same device, and even the results were given a duration of approximately 12 years. Calibrations and controls are made on a daily basis in laboratory equipments, and patient results may show differences between days due to this reason [2] . It is likely that the devices being operated have changed according to the tender laws. Since each method and device has different characteristics, it is necessary for the reader to know what method they are working with. It is of great importance to study all results on the same day and on the same device in such studies. Communication with the laboratory specialist will reduce measurement uncertainties.
In this study, devices used for automatic blood counting are not specified, and it should be noted that if more than one automatic blood count device is used, MPV results may be significantly affected [3] . It has been reported that MPV measurements can vary by up to 40% in different whole blood count devices [4] . This parameters can be affected from many diseases and conditions (hypertension, hematologic and renal diseases, heart failure, chronic infections, hepatic disorders, acute inflammatory diseases, autoimmune diseases, other cancers and drug use) [5] . There is no statement that these diseases are excluded from the study. The non-exclusion of these conditions will constitute question marks for the study.
Platelet and lymphocyte counts have different reference intervals according to age and sex [6] . There is a statistically significant difference between age and gender in the comparison of benign and malignant patients in the study. Therefore, the comparison of patients with different age and gender will reduce the value of the results. 
